Chemical proteomics applied to target identification and drug discovery

被引:25
|
作者
Verhelst, SHL [1 ]
Bogyo, M [1 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
关键词
D O I
10.2144/05382TE01
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:175 / 177
页数:3
相关论文
共 50 条
  • [31] Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
    Hedl, Thomas J.
    San Gil, Rebecca
    Cheng, Flora
    Rayner, Stephanie L.
    Davidson, Jennilee M.
    De Luca, Alana
    Villalva, Maria D.
    Ecroyd, Heath
    Walker, Adam K.
    Lee, Albert
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [32] Chemical Proteomics as a Tool in Target Discovery of Bioactive Small Molecules
    Margarucci, L.
    Monti, M. C.
    Riccio, R.
    Casapullo, A.
    JOURNAL OF BIOTECHNOLOGY, 2010, 150 : S31 - S31
  • [33] Membrane proteomics for leukemia classification and drug target identification
    Kohnke, Philippa L.
    Mulligan, Stephen P.
    Christopherson, Richard I.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2009, 11 (06) : 603 - 610
  • [34] Computational approaches in target identification and drug discovery
    Katsila, Theodora
    Spyroulias, Georgios A.
    Patrinos, George P.
    Matsoukas, Minos-Timotheos
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2016, 14 : 177 - 184
  • [36] Human tissue in target identification and drug discovery
    Palfreyman, MG
    DRUG DISCOVERY TODAY, 2002, 7 (07) : 407 - 409
  • [37] Proteomics in drug discovery
    Hewick, RM
    Lu, ZJ
    Wang, JH
    PROTEOME CHARACTERIZATION AND PROTEOMICS, 2003, 65 : 309 - 342
  • [38] Proteomics for drug discovery
    Oda, Yoshiya
    DRUG METABOLISM REVIEWS, 2006, 38 : 20 - 20
  • [39] Proteomics and drug discovery
    Jain, KK
    PROTEOMICS IN NEPHROLOGY, 2004, 141 : 308 - 327
  • [40] Proteomics in drug discovery
    Wang, JH
    Hewick, RM
    DRUG DISCOVERY TODAY, 1999, 4 (03) : 129 - 133